In the largest Brazilian cohort of severe TR, constructed with the aid of AI, the disease demonstrated high clinical and prognostic complexity and may support multicenter studies.
Abstract
Abstract Background: Tricuspid regurgitation (TR) is prevalent and challenging to manage. There is a high mortality rate associated with isolated surgery and late referral for intervention. Additionally, there has been a recent expansion of transcatheter therapies. In Brazil, there is a lack of data and validation of prognostic tools. Objective: To investigate and define clinical, laboratory, and echocardiographic data from patients with severe TR based on variables collected through the training of an artificial intelligence (AI) model. Methods: This observational, single-center, non-interventional, retrospective study was based on 71,911 echocardiographic reports performed between 2021 and 2024. A natural language processing (NLP) model was developed in Python to identify cases of severe TR, extract variables, and perform automated calculation of the TRI-SCORE and EuroSCORE II, which were subsequently reviewed. A two-tailed p-value < 0.05 was considered statistically significant. Results: A total of 803 patients with severe TR were identified. The mean age was 68.8 ± 13.5 years, and 64.1% were female. Hypertension (71.7%) and atrial fibrillation (69.4%) were the most prevalent comorbidities. Secondary etiology predominated (96.8%), mainly associated with mitral valve disease (68.5%). Surgical risk was high (medians: EuroSCORE II = 13.4%; TRI-SCORE = 7). Mortality was 17.1%. In the secondary mortality analysis, multivariable regression identified independent predictors, such as high-risk TRI-SCORE (relative risk [RR] 2.19; 95% CI 1.14-4.21) and increased creatinine (RR 3.13; 95% CI 1.91-5.14). Conclusions: In the largest Brazilian cohort of severe TR, constructed with the aid of AI, the disease demonstrated high clinical and prognostic complexity. The application of NLP to large echocardiographic databases proved to be efficient and may support multicenter studies.
The clinician–AI synergy can accelerate diagnosis and individualize treatment in pericardial and myocardial diseases and justify dual-chamber ICD implantation and personalized transplantation risk assessment.
M. Galkina, O. V. Fatenkov, J. R. Vagizov et al.· Manager Zdravookhranenia· 0 citations
Mitral regurgitation (MR) is among the most prevalent valvular heart diseases. We developed and externally validated a machine learning (ML)‐based mortality prediction model for patients with significant MR. From the ChinaValvular Heart Disease (China‐VHD) registry, 6323 patients with moderate or greater MR were random...
Objectives: Severe mitral regurgitation (MR) has been associated with significant morbidity and mortality, necessitating effective risk stratification. The H2FPEF score has demonstrated prognostic value in other cardiac disorders. This study evaluates the prognostic utility of a modified version of the H2FPEF score for...
H. Wong, T. Koh, Zong-Rui Bai et al.· Journal of Cardiovascular De...· 0 citations
Background Contemporary guideline-based assessment of left ventricular diastolic function and filling pressure requires multiple echocardiographic parameters that may not be routinely acquired in real-world clinical practice. Objectives The aim of the study was to compare the prognostic and diagnostic performance of a...
M. Tokodi, N. Kagiyama, Ambarish Pandey et al.· JACC: Advances· 0 citations
The authors' explainable, multimodal AI-based model for predicting long-term outcomes in the TAVI population substantially outperformed conventional risk scores and showed robust generalisability across diverse TAVI populations and clinical settings.
I. Shiri, D. Tomii, Giovanni Baj et al.· The Lancet Digital Health· 0 citations
A machine learning (ML) model using two preprocedural cardiac CT-derived metrics, automatically extractable with open-source tools, predicts 1-year mortality after TAVI.
D. Vignale, Andrea Corvaglia, A. Palmisano et al.· Radiology Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.